{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:50:21Z","timestamp":1791478221878,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Norwegian Research Council","doi-asserted-by":"crossref","award":["192477"],"award-info":[{"award-number":["192477"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005416","name":"Norwegian Research Council","doi-asserted-by":"crossref","award":["220829"],"award-info":[{"award-number":["220829"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.vaccine.2014.09.063","type":"journal-article","created":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T18:36:07Z","timestamp":1412879767000},"page":"6631-6638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt"],"prefix":"10.1016","volume":"32","author":[{"given":"G.","family":"Tunheim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M.","family":"N\u00e6ss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Acevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5.K.","family":"Fjeldheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Bolstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Aase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Zayas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Rosenqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Norheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl.","key":"10.1016\/j.vaccine.2014.09.063_bib0005","first-page":"1","article-title":"Cerebrospinal meningitis in Africa","volume":"28","author":"Lapeyssonnie","year":"1963","journal-title":"Bull World Health Org"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2014.09.063_bib0010","doi-asserted-by":"crossref","first-page":"B13","DOI":"10.1016\/j.vaccine.2009.04.062","article-title":"Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution","volume":"27","author":"LaForce","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0015","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/cid\/cis896","article-title":"The endgame for serogroup a meningococcal disease in Africa","volume":"56","author":"Maiden","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0020","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/cid\/cis892","article-title":"Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity","volume":"56","author":"Kristiansen","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2014.09.063_bib0025","doi-asserted-by":"crossref","first-page":"B40","DOI":"10.1016\/j.vaccine.2011.12.073","article-title":"Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience","volume":"30","author":"Djingarey","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0030","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1016\/j.vaccine.2013.04.036","article-title":"Emergence of serogroup X meningococcal disease in Africa: need for a vaccine","volume":"31","author":"Xie","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0035","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/511646","article-title":"Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger","volume":"44","author":"Boisier","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0040","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3201\/eid1306.070042","article-title":"Serogroup X in meningococcal disease, Western Kenya","volume":"13","author":"Materu","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0045","doi-asserted-by":"crossref","first-page":"e19513","DOI":"10.1371\/journal.pone.0019513","article-title":"Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso","volume":"6","author":"Delrieu","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0050","doi-asserted-by":"crossref","first-page":"e46019","DOI":"10.1371\/journal.pone.0046019","article-title":"Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine","volume":"7","author":"Caugant","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0055","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4269\/ajtmh.2009.80.619","article-title":"Epidemiology and risk factors for serogroup X meningococcal meningitis during an outbreak in western Kenya, 2005\u20132006","volume":"80","author":"Mutonga","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0060","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.vaccine.2012.12.022","article-title":"Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa","volume":"31","author":"Hong","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0065","doi-asserted-by":"crossref","first-page":"e79304","DOI":"10.1371\/journal.pone.0079304","article-title":"The development of an experimental multiple serogroups vaccine for Neisseria meningitidis","volume":"8","author":"Pinto","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0070","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.biologicals.2013.12.001","article-title":"Process development and immunogenicity studies on a serogroup \u2018X\u2019 Meningococcal polysaccharide conjugate vaccine","volume":"42","author":"Chilukuri","year":"2014","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0075","doi-asserted-by":"crossref","first-page":"19077","DOI":"10.1073\/pnas.1314476110","article-title":"Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X","volume":"110","author":"Micoli","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0080","first-page":"437","article-title":"New vaccine Strategies against Neisseria meningitidis serogroup X [abstract]","volume":"21","author":"Acevedo","year":"2014","journal-title":"Int J Infect Dis: IJID: Off Publ Int Soc Infect Dis"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0085","series-title":"076 Characterization and immunogenicity of Neisseria meningitidis serogroup X capsular polysaccharide a step forward for rapid diagnostic tests [abstract]","author":"Agnememel","year":"2013"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0090","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1016\/j.vaccine.2014.03.068","article-title":"A broadly-protective vaccine against meningococcal disease in sub-Saharan Africa based on generalized modules for membrane antigens (GMMA)","volume":"32","author":"Koeberling","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0095","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.4161\/hv.24129","article-title":"Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future","volume":"9","author":"Holst","year":"2013","journal-title":"Hum Vaccine Immunother"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0100","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0105","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-3083.2012.02709.x","article-title":"An outer membrane vesicle vaccine for prevention of serogroup A and W-135 meningococcal disease in the African meningitis belt","volume":"76","author":"Norheim","year":"2012","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0110","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.1016\/j.vaccine.2013.09.044","article-title":"Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines","volume":"31","author":"Tunheim","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0115","series-title":"NeisseriaVaccines","article-title":"Immunogenicity of meningococcal serogroup X polysaccharide and outer membrane vesicles [abstract]","author":"Norheim","year":"2011"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0120","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3201\/eid0805.010227","article-title":"Clonal groupings in serogroup X Neisseria meningitidis","volume":"8","author":"Gagneux","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0125","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1086\/597806","article-title":"Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa","volume":"199","author":"Beernink","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0130","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0003-2697(78)90586-9","article-title":"A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples","volume":"87","author":"Markwell","year":"1978","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0135","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.1016\/j.vaccine.2012.07.032","article-title":"Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies","volume":"30","author":"Xie","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0140","first-page":"157","article-title":"Nucleotide sequencing of antigen genes of Neisseria meningitidis","volume":"67","author":"Urwin","year":"2001","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0145","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/1471-2105-11-595","article-title":"BIGSdb: scalable analysis of bacterial genome variation at the population level","volume":"11","author":"Jolley","year":"2010","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0150","series-title":"Meningococcal Vaccines: Methods and Protocols","first-page":"275","article-title":"Immunoblot analysis of sera from patients and vaccinees","author":"Wedege","year":"2001"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0155","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The multilaboratory study group","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0160","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0264-410X(02)00774-0","article-title":"Comparison of functional immune responses in humans after intranasal and intramuscular immunisations with outer membrane vesicle vaccines against group B meningococcal disease","volume":"21","author":"Aase","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0165","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1016\/j.vaccine.2005.02.021","article-title":"Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis","volume":"23","author":"Norheim","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/clin.1997.4360","article-title":"Vaccine-induced IgG antibodies to the linear epitope on the PorB outer membrane protein promote opsonophagocytosis of Neisseria meningitidis by human neutrophils","volume":"84","author":"Delvig","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0175","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1128\/IAI.70.8.4028-4034.2002","article-title":"Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis","volume":"70","author":"Wright","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0180","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/infdis\/167.5.1065","article-title":"The 5C protein of Neisseria meningitidis is highly immunogenic in humans and induces bactericidal antibodies","volume":"167","author":"Rosenqvist","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0185","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12026-013-8427-6","article-title":"Combined meningococcal serogroup A and W outer-membrane vesicles activate cell-mediated immunity and long-term memory responses against non-covalent capsular polysaccharide A","volume":"58","author":"Romeu","year":"2013","journal-title":"Immunol Res"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0190","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1128\/iai.1.1.8-14.1970","article-title":"Isolation and characterization of Neisseria meningitidis groups A, C, X, and Y polysaccharide antigens","volume":"1","author":"Robinson","year":"1970","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0195","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1016\/S0021-9258(19)42390-9","article-title":"Studies on the group-specific polysaccharide of Neisseria meningitidis serogroup X and an improved procedure for its isolation","volume":"249","author":"Bundle","year":"1974","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0200","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.vaccine.2008.11.065","article-title":"Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa","volume":"27","author":"Lee","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0205","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1586\/14760584.1.1.75","article-title":"Meningococcal vaccines","volume":"1","author":"Bethell","year":"2002","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0210","doi-asserted-by":"crossref","first-page":"16","DOI":"10.37757\/MR2007V9.N1.6","article-title":"Cuban meningococcal BC vaccine: experiences & contributions from 20 years of application","volume":"9","author":"Sotolongo","year":"2007","journal-title":"MEDICC Rev"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0215","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1016\/j.vaccine.2010.05.014","article-title":"Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus","volume":"28","author":"Giuliani","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0220","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1073\/pnas.1019751108","article-title":"Neisseria meningitidis is structured in clades associated with restriction modification systems that modulate homologous recombination","volume":"108","author":"Budroni","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0225","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1084\/jem.20020407","article-title":"NadA, a novel vaccine candidate of Neisseria meningitidis","volume":"195","author":"Comanducci","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0230","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1086\/424464","article-title":"Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease","volume":"190","author":"Litt","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0235","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1128\/JCM.43.10.5129-5135.2005","article-title":"Molecular epidemiology of Neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes","volume":"43","author":"Nicolas","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2014.09.063_bib0240","doi-asserted-by":"crossref","first-page":"e1302","DOI":"10.1371\/journal.pntd.0001302","article-title":"Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development","volume":"5","author":"Pajon","year":"2011","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14013413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14013413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T05:08:43Z","timestamp":1689570523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14013413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":48,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0264410X14013413"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.09.063","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.09.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}